These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 18948614)
1. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Laskowitz DT; Kasner SE; Saver J; Remmel KS; Jauch EC; Stroke; 2009 Jan; 40(1):77-85. PubMed ID: 18948614 [TBL] [Abstract][Full Text] [Related]
2. Novel diagnostic test for acute stroke. Lynch JR; Blessing R; White WD; Grocott HP; Newman MF; Laskowitz DT Stroke; 2004 Jan; 35(1):57-63. PubMed ID: 14671250 [TBL] [Abstract][Full Text] [Related]
3. Discriminative capacity of biomarkers for acute stroke in the emergency department. Glickman SW; Phillips S; Anstrom KJ; Laskowitz DT; Cairns CB J Emerg Med; 2011 Sep; 41(3):333-9. PubMed ID: 20417054 [TBL] [Abstract][Full Text] [Related]
4. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study. Bustamante A; López-Cancio E; Pich S; Penalba A; Giralt D; García-Berrocoso T; Ferrer-Costa C; Gasull T; Hernández-Pérez M; Millan M; Rubiera M; Cardona P; Cano L; Quesada H; Terceño M; Silva Y; Castellanos M; Garces M; Reverté S; Ustrell X; Marés R; Baiges JJ; Serena J; Rubio F; Salas E; Dávalos A; Montaner J Stroke; 2017 Sep; 48(9):2419-2425. PubMed ID: 28716979 [TBL] [Abstract][Full Text] [Related]
5. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284 [TBL] [Abstract][Full Text] [Related]
6. Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study. Barbieri A; Giuliani E; Carone C; Pederzoli F; Mascheroni G; Greco G; Stucchi C; Genedani S Minerva Anestesiol; 2013 Jul; 79(7):750-7. PubMed ID: 23511364 [TBL] [Abstract][Full Text] [Related]
7. Plasma biomarkers in the diagnosis of acute ischemic stroke. Kim MH; Kang SY; Kim MC; Lee WI Ann Clin Lab Sci; 2010; 40(4):336-41. PubMed ID: 20947807 [TBL] [Abstract][Full Text] [Related]
8. A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department. Montaner J; Mendioroz M; Ribó M; Delgado P; Quintana M; Penalba A; Chacón P; Molina C; Fernández-Cadenas I; Rosell A; Alvarez-Sabín J J Intern Med; 2011 Aug; 270(2):166-74. PubMed ID: 21198992 [TBL] [Abstract][Full Text] [Related]
9. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway. Montaner J; Mendioroz M; Delgado P; García-Berrocoso T; Giralt D; Merino C; Ribó M; Rosell A; Penalba A; Fernández-Cadenas I; Romero F; Molina C; Alvarez-Sabín J; Hernández-Guillamon M J Proteomics; 2012 Aug; 75(15):4758-65. PubMed ID: 22343074 [TBL] [Abstract][Full Text] [Related]
11. Serum protein S100β is a diagnostic biomarker for distinguishing posterior circulation stroke from vertigo of nonvascular causes. Purrucker JC; Herrmann O; Lutsch JK; Zorn M; Schwaninger M; Bruckner T; Auffarth GU; Veltkamp R Eur Neurol; 2014; 72(5-6):278-84. PubMed ID: 25323105 [TBL] [Abstract][Full Text] [Related]
12. Use of the Triage Stroke Panel in a neurologic emergency service. Sibon I; Rouanet F; Meissner W; Orgogozo JM Am J Emerg Med; 2009 Jun; 27(5):558-62. PubMed ID: 19497461 [TBL] [Abstract][Full Text] [Related]
13. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Foerch C; Wunderlich MT; Dvorak F; Humpich M; Kahles T; Goertler M; Alvarez-Sabín J; Wallesch CW; Molina CA; Steinmetz H; Sitzer M; Montaner J Stroke; 2007 Sep; 38(9):2491-5. PubMed ID: 17673718 [TBL] [Abstract][Full Text] [Related]
14. The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Wang L; Wei C; Deng L; Wang Z; Song M; Xiong Y; Liu M J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1653-1665. PubMed ID: 29598905 [TBL] [Abstract][Full Text] [Related]
15. A biomarker panel: an additional resource in acute stroke evaluation? Kimura T; Nishikawa T Minerva Anestesiol; 2013 Jul; 79(7):711-2. PubMed ID: 23558768 [No Abstract] [Full Text] [Related]
16. Value of biomarker-based diagnostic test in differential diagnosis of hemorrhagic-ischemic stroke. Kavalci C; Genchallac H; Durukan P; Cevik Y Bratisl Lek Listy; 2011; 112(7):398-401. PubMed ID: 21744736 [TBL] [Abstract][Full Text] [Related]
17. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation. Undén J; Strandberg K; Malm J; Campbell E; Rosengren L; Stenflo J; Norrving B; Romner B; Lindgren A; Andsberg G J Neurol; 2009 Jan; 256(1):72-7. PubMed ID: 19221847 [TBL] [Abstract][Full Text] [Related]
18. Use of biomarkers in triage of patients with suspected stroke. Vanni S; Polidori G; Pepe G; Chiarlone M; Albani A; Pagnanelli A; Grifoni S J Emerg Med; 2011 May; 40(5):499-505. PubMed ID: 19217237 [TBL] [Abstract][Full Text] [Related]
19. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Jauch EC; Lindsell C; Broderick J; Fagan SC; Tilley BC; Levine SR; Stroke; 2006 Oct; 37(10):2508-13. PubMed ID: 16960091 [TBL] [Abstract][Full Text] [Related]
20. N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke. Fonseca AC; Matias JS; Pinho e Melo T; Falcão F; Canhão P; Ferro JM Int J Stroke; 2011 Oct; 6(5):398-403. PubMed ID: 21645267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]